231 related articles for article (PubMed ID: 27799303)
1. Different Doublecortin (DCX) Patient Alleles Show Distinct Phenotypes in Cultured Neurons: EVIDENCE FOR DIVERGENT LOSS-OF-FUNCTION AND "OFF-PATHWAY" CELLULAR MECHANISMS.
Yap CC; Digilio L; McMahon L; Roszkowska M; Bott CJ; Kruczek K; Winckler B
J Biol Chem; 2016 Dec; 291(52):26613-26626. PubMed ID: 27799303
[TBL] [Abstract][Full Text] [Related]
2. A dominant dendrite phenotype caused by the disease-associated G253D mutation in doublecortin (DCX) is not due to its endocytosis defect.
Yap CC; Digilio L; Kruczek K; Roszkowska M; Fu XQ; Liu JS; Winckler B
J Biol Chem; 2018 Dec; 293(49):18890-18902. PubMed ID: 30291144
[TBL] [Abstract][Full Text] [Related]
3. Doublecortin (DCX) mediates endocytosis of neurofascin independently of microtubule binding.
Yap CC; Vakulenko M; Kruczek K; Motamedi B; Digilio L; Liu JS; Winckler B
J Neurosci; 2012 May; 32(22):7439-53. PubMed ID: 22649224
[TBL] [Abstract][Full Text] [Related]
4. Mitotic impairment by doublecortin is diminished by doublecortin mutations found in patients.
Couillard-Despres S; Uyanik G; Ploetz S; Karl C; Koch H; Winkler J; Aigner L
Neurogenetics; 2004 Jun; 5(2):83-93. PubMed ID: 15045646
[TBL] [Abstract][Full Text] [Related]
5. Colocalization of doublecortin with the microtubules: an ex vivo colocalization study of mutant doublecortin.
Yoshiura K; Noda Y; Kinoshita A; Niikawa N
J Neurobiol; 2000 May; 43(2):132-9. PubMed ID: 10770842
[
